Schizophrenia Clinical Trials in Chicago

Showing 81-100 of 118 trials

Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults

NCT01266174

The purpose of this study is to determine if eltoprazine (as an adjunct to anti-psychotic medication) improves one or more aspects of cognitive impairment in adult schizophrenic patients.

Cognitive ImpairmentSchizophrenia

Amarantus BioScience Holdings, Inc.31 participantsStarted Aug 2011

Los Angeles, California, United States • Chicago, Illinois, United States • Catonsville, Maryland, United States +3 more locations

COMPLETEDNA2.2 miles

Medication Adherence in Schizophrenia: Development of a CBT-Based Intervention

NCT00980252

This is a randomized pilot study of an intervention based on principles of Cognitive Behavioral Therapy (CBT). This intervention is the Health Dialogue Intervention (HDI) and will be compared to a traditional medical model of psychoeducation known as Team Solutions (TS) for first-episode schizophrenia patients. Outcomes include the acceptance of HDI and TS, compare adherence attitudes at the end of the treatment intervention, and to compare the time until the first episode of nonadherence.

SchizophreniaPsychotic Disorders

University of Illinois at Chicago34 participantsStarted Nov 2009

Chicago, Illinois, United States

COMPLETEDPhase 42.2 miles

Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone

NCT00535132

The purpose of this study is to evaluate medication satisfaction after at least 4 weeks of paliperidone ER (extended-release), an antipsychotic, treatment in patients with schizophrenia who were previously taking either 4 or 6 mg of risperidone daily by mouth, but who are not satisfied with their treatment.

Schizophrenia

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.201 participantsStarted Oct 2007

Cerritos, California, United States • Garden Grove, California, United States • Huntington Beach, California, United States +37 more locations

Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults

Medication Adherence in Schizophrenia: Development of a CBT-Based Intervention

Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone

Schizophrenia Trials in Other Cities

Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

Thinking Skills for Work in Severe Mental Illness

Improving Antipsychotic Adherence Among Patients With Serious Mental Illness

A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307)

Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia

Study Evaluating Vabicaserin in Subjects With Schizophrenia

Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness

Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia

Lurasidone Pediatric Pharmacokinetics Study

Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.

Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia

Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia

Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia

Other Conditions in Chicago